Found: 13
Select item for more details and to access through your institution.
Immune-Related Adverse Events in Patients with Lung Cancer.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 11, p. 1259, doi. 10.1007/s11912-023-01462-w
- By:
- Publication type:
- Article
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1306311
- By:
- Publication type:
- Article
Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0098021
- By:
- Publication type:
- Article
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2805, doi. 10.3390/cancers16162805
- By:
- Publication type:
- Article
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 935, doi. 10.3390/cancers16050935
- By:
- Publication type:
- Article
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3372, doi. 10.3390/cancers15133372
- By:
- Publication type:
- Article
Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2899, doi. 10.3390/cancers15112899
- By:
- Publication type:
- Article
RefAI: a GPT-powered retrieval-augmented generative tool for biomedical literature recommendation and summarization.
- Published in:
- Journal of the American Medical Informatics Association, 2024, v. 31, n. 9, p. 2030, doi. 10.1093/jamia/ocae129
- By:
- Publication type:
- Article
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 6, p. 2085, doi. 10.1002/cam4.2869
- By:
- Publication type:
- Article
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0590-3
- By:
- Publication type:
- Article
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1417175
- By:
- Publication type:
- Article
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.959500
- By:
- Publication type:
- Article